CDKN2A Gene Pancreatic Cancer/Melanoma Syndrome Familial NGS Genetic DNA Test
Introduction
The CDKN2A Gene Pancreatic Cancer/Melanoma Syndrome Familial NGS Genetic DNA Test is an advanced diagnostic tool that plays a vital role in identifying genetic predispositions to pancreatic cancer and melanoma. Understanding your genetic risk can aid in early detection and prevention strategies, making this test essential for individuals with a family history of these cancers.
What the Test Measures
This test specifically analyzes the CDKN2A gene, which is known to influence the risk of developing pancreatic cancer and melanoma. By utilizing next-generation sequencing (NGS) technology, the test detects mutations in this gene that may indicate a hereditary predisposition to these malignancies.
Who Should Consider This Test
Individuals who have a family history of pancreatic cancer or melanoma, especially those with multiple affected relatives, should consider this test. Symptoms that may warrant testing include:
- Unexplained weight loss
- Abdominal pain
- Changes in skin lesions
- Family history of pancreatic cancer or melanoma
Additionally, those with risk factors such as age, ethnicity, or personal medical history may benefit from this genetic assessment.
Benefits of Taking the Test
- Identifies genetic risks, allowing for proactive health management.
- Facilitates informed decisions regarding surveillance and preventive measures.
- Provides valuable information for family members regarding their own risk.
- Enhances communication with healthcare providers about personalized care strategies.
Understanding Your Results
Results from the CDKN2A Gene Pancreatic Cancer/Melanoma Syndrome Familial NGS Genetic DNA Test will indicate whether mutations are present. A positive result suggests an increased risk of developing these cancers, while a negative result may offer peace of mind. It is essential to discuss your results with a healthcare professional for comprehensive interpretation and guidance on subsequent steps.
Test Details and Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| CDKN2A Gene Pancreatic Cancer/Melanoma Syndrome Familial NGS Genetic DNA Test | 40,000 KSh | 56,000 KSh |
Additional Information
Turnaround time for results is approximately 3 to 4 weeks. The sample type required for the test includes blood or extracted DNA, or one drop of blood on an FTA card. It is crucial to have a clinical history of the patient and to undergo a genetic counseling session to create a pedigree chart of family members affected by the CDKN2A gene.
Book Your Test Today!
We have branches across Kenya, including Nairobi, Mombasa, and Kisumu, and offer home sample collection services. Don’t wait to understand your genetic risk—book your test now or call us at +254711564616 for more information.
